• About NeuroStar TMS^®
  • What is NeuroStar TMS Therapy^®?
  • How Does it Work?
  • Depression Treatment Guidelines
• NeuroStar TMS Therapy
  • Clinical Results
  • Safety Profile
  • What to Expect with Therapy
  • Patient Experiences
  • NeuroStar FAQs
  • Educational Video
• About Depression
  • Depression Symptoms
  • Treating Depression
  • Depression FAQs
  • NeuroStar for Depression
• Health Insurance Coverage
  • Reimbursement Support
• NeuroStar^® Resources
  • NeuroStar^® In The News
  • Recent Press Releases
  • Press Archive
  • Patient Education Webinars
  • NeuroStar^® Patient Corner
• Contact Us
  • General Contact Information

What is NeuroStar TMS Therapy^®?

NeuroStar TMS Therapy is a safe and effective non-drug treatment for depression. The therapy works through TMS (transcranial magnetic stimulation), in which precisely targeted magnetic pulses stimulate key areas of the brain that are underactive in patients with depression.

• NeuroStar TMS Therapy has been proven safe and effective for treating depression.
  • Clinically proven in trials with 800 patients^1-4
  • More than 10,000 patients treated⁵
  • Technology similar to magnetic resonance imaging (MRI), which has a track record of safety
• NeuroStar TMS Therapy is free of the side effects that patients most often experience with antidepressant medications. The most common side effect with NeuroStar TMS Therapy is pain or discomfort at or near the treatment area.
• Each NeuroStar TMS Therapy treatment takes about 37 minutes and is conducted in the doctor’s office, five days a week, for approximately four to six week.
• NeuroStar patients are awake and alert during treatment and can go back to their normal activities immediately after treatment.

NeuroStar TMS Therapy a novel treatment approach to achieving remission that is bringing new hope every day to patients suffering from major depression. TMS Therapy may not be right for everyone. Talk to a NeuroStar physician to find out if this proven depression treatment is right for you.

Learn how NeuroStar TMS Therapy treats depression

1. Demitrack MA, Thase ME. Clinical significance of transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant depression: synthesis of recent data. Psychopharmacol Bull. 2009;42(2):5-38.
2. O’Reardon JP, Solvason HB, Janicak PG, et al. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry. 2007;62(11):1208-1216.
3. George MS, Lisanby SH, Avery D, et al. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial. Arch Gen Psychiatry. 2010;67(5):507-516.
4. Carpenter LL, Janicak PG, Aaronson ST, et al. Transcranial magnetic stimulation (TMS) for major depression: a multisite naturalistc, observational study of acute treatment outcomes in clinical practice. Depress Anxiety. 2012;29(7):587-596.
5. Janicak PG, Nahas Z, Lisanby SH, et al. Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study. Brain Stimul. 2010;3(4):187-199.
6. Neuronetics, Inc., data on file.